Tauroursodeoxycholate (dihydrate) (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Tauroursodeoxycholate (dihydrate) (Standard)
Description:
Tauroursodeoxycholate (dihydrate) (Standard) is the analytical standard of Tauroursodeoxycholate (dihydrate) . This product is intended for research and analytical applications. Tauroursodeoxycholate (Tauroursodeoxycholic acid; TDUCA) dihydrate is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK[1][2].Product Name Alternative:
Tauroursodeoxycholic acid (dihydrate) (Standard) ; TUDCA (dihydrate) (Standard) ; UR 906 (dihydrate) (Standard)UNSPSC:
12352100Target:
Apoptosis; Caspase; Endogenous Metabolite; ERK; Reference StandardsRelated Pathways:
Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Others; Stem Cell/WntField of Research:
CancerSmiles:
C[C@H] (CCC (NCCS (=O) (O) =O) =O) [C@H]1CC[C@@]2 ([H]) [C@]3 ([H]) [C@@H] (O) C[C@]4 ([H]) C[C@H] (O) CC[C@]4 (C) [C@@]3 ([H]) CC[C@]12C.O.OMolecular Formula:
C26H49NO8SMolecular Weight:
535.73References & Citations:
[1]Kim SY, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK viaPKCα-mediated MKP-1 induction. Cardiovasc Res. 2011 Nov 1;92 (2) :307-16.|[2]Qin Y, et al. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Eur J Vasc Endovasc Surg. 2017 Mar;53 (3) :337-345.Shipping Conditions:
Room temperatureScientific Category:
Reference StandardsClinical Information:
LaunchedCAS Number:
117609-50-4
